Benitec Biopharma (BNTC) Receivables (2019 - 2025)

Benitec Biopharma (BNTC) reported Receivables of $130000.0 for Q4 2025, up 1757.14% sequentially from $7000.0 in Q3 2025.

Benitec Biopharma (BNTC) Receivables (2019 - 2025) Analysis & Trends

Benitec Biopharma (BNTC) has 7 years of Receivables data on file, last reported at $130000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Receivables changed N/A year-over-year to $130000.0; the trailing twelve-month figure through Dec 2025 stood at $130000.0 (changed N/A YoY), and the FY2025 full-year result was $33000.0, down 85.59% from the prior year.
  • Receivables grew to $130000.0 in Q4 2025, from $7000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $229000.0 in Q2 2024 to a low of $3000.0 in Q3 2021.
  • A 5-year average of $42000.0 and a median of $25000.0 in 2021 frame the typical range for Receivables.
  • Across the five-year window, Receivables surged 1733.33% in 2023 and plunged 94.34% in 2025, its largest moves.
  • Tracing BNTC's Receivables over 5 years: stood at $5000.0 in 2021, then surged by 1260.0% to $68000.0 in 2022, then fell by 22.06% to $53000.0 in 2023, then plunged by 92.45% to $4000.0 in 2024, then surged by 3150.0% to $130000.0 in 2025.
  • Business Quant data shows BNTC's Receivables at $130000.0 in Q4 2025, $7000.0 in Q3 2025, and $33000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 4.97 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 938.02 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.13 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.93 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Benitec Biopharma 46.45 Mn 46.45 Mn - 130,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 130,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 33,000.00
Mar 31, 2025 3,000.00
Sep 30, 2024 4,000.00
Jun 30, 2024 229,000.00
Mar 31, 2024 53,000.00
Dec 31, 2023 53,000.00
Sep 30, 2023 53,000.00
Jun 30, 2023 55,000.00
Mar 31, 2023 56,000.00
Dec 31, 2022 68,000.00
Sep 30, 2022 3,000.00
Jun 30, 2022 3,000.00
Mar 31, 2022 5,000.00
Dec 31, 2021 5,000.00
Sep 30, 2021 3,000.00
Jun 30, 2021 25,000.00
Mar 31, 2021 10,000.00
Dec 31, 2020 42,000.00